Retraction notice to “In vitro anticholinergic drugs affect CD8+ peripheral blood T-cells apoptosis in COPD” [Immunobiology 217/3 (2012) 345–353, (S0171298511001446), (10.1016/j.imbio.2011.07.013)];In vitro anticholinergic drugs affect CD8+ peripheral blood T-cells apoptosis in COPD

Immunobiology

Volumn 217, Issue 3, 2012, Pages 345-353

  Profita, Mirella ^a   Riccobono, Loredana ^a   Montalbano, Angela Marina ^a   Bonanno, Anna ^a   Ferraro, Maria ^a   Albano, Giusy Daniela ^a   Gerbino, Stefania ^a   Casarosa, Paola ^b   Pieper, Michael Paul ^b   Gjomarkaj, Mark ^a  

^a CNR Consiglio Nazionale delle Ricerche   (Italy)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Caspases; NF B pathway; Non neuronal components of cholinergic system; Systemic inflammation

Indexed keywords

ACETYLCHOLINE; CASPASE 3; CASPASE 8; CHOLINE; CHOLINE ACETYLTRANSFERASE; CHOLINERGIC RECEPTOR BLOCKING AGENT; HEMICHOLINIUM 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MUSCARINIC M3 RECEPTOR; TIOTROPIUM BROMIDE;

ADULT; APOPTOSIS; ARTICLE; CD3+ T LYMPHOCYTE; CD4 CD8 RATIO; CD8+ T LYMPHOCYTE; CELL CULTURE; CELL ISOLATION; CHOLINERGIC SYSTEM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; LUNG FUNCTION TEST; MALE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SMOKING;

EID: 84856428464     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2024.152800     Document Type: Erratum

References (28)

1. Baraldo S., Lokar Oliani K., Turato G., Zuin R., Saetta M. The role of lymphocytes in the pathogenesis of asthma and COPD. Curr. Med. Chem. 2007, 21(14).
2. Barczyk A., Pierzchala W., Kon O.M., Cosio B., Adcock I.M., Barnes P.J. Cytokine production by bronchoalveolar lavage T lymphocytes in chronic obstructive pulmonary disease. J. Allergy Clin. Immunol. 2006, 117:1484-1492.
3. Bateman E.D., Rennard S., Barnes P.J., Dicpinigaitis P.V., Gosens R., Gross N.J., Nadel J.A., Pfeifer M., Racke K., Rabe K.F., Rubin B.K., Welte T., Wessler I. Alternative mechanisms for Tiotropium. Pulm. Pharmacol. Ther. 2009, 22:533-542.
4. Buhling F., Lieder N., Kuhlmann U.C., Waldburg N., Welte T. Tiotropium suppresses acetylcholine induced release of chemotactic mediators in vitro. Respir. Med. 2007, 101(November (11)):2386-2394.
5. Carbone A., Rodeck U., Mauri F.A., Sozzi M., Gaspari F., Smirne C., Prati A., Addeo A., Novarino A., Robecchi A., Bertetto O., Emanuelli G., Bellone G. Human pancreatic carcinoma cells secrete bioactive interleukin-18 after treatment with 5-fluorouracil: implications for anti-tumor immune response. Cancer Biol. Ther. 2005, 4:231-241.
6. Distelhorst C.W. Recent insights into the mechanism of glucocorticosteroid-induced apoptosis. Cell Death Differ. 2002, 9(9):6-19.
7. Fujii T., Takada-Takatori Y., Kawashima K. Basic and clinical aspects of non-neuronal acetylcholine: expression of an independent non-neuronal cholinergic system in lymphocytes and its clinical significance in immunotherapy. J. Pharm. Sci. 2008, 106:186-192.
8. Glader P., Moller S., Lilja J., Wieslander E., Lofdahl C.G., von Wachenfeldt K. Cigarette smoke extract modulates respiratory defence mechanisms through effects on T-cells and airway epithelial cells. Respir. Med. 2006, 100(May (5)):818-827.
9. Gosens R., Rieks D., Meurs H., Ninaber D.K., Rabe K.F., Nanninga J., Kolahian S., Halayko A.J., Hiemstra P.S., Zuyderduyn S. Muscarinic M3 receptor stimulation increases cigarette smoke-induced IL-8 secretion by human airway smooth muscle cells. Eur. Respir. J. 2009, 34:1436-1443.
10. Green D.R. Death and NF-kappaB in T cell activation: life and edge. Mol. Cell 2003, 11:551-552.
11. Gwilt C.R., Donnelly L.E., Rogers DF The non-neuronal cholinergic system in the airways: an unappreciated regulatory role in pulmonary inflammation?. Pharmacol. Ther. 2007, 115(2):208-222.
12. Hallett J.M., Leitch A.E., Riley N.A., Duffin R., Haslett C., Rossi A.G. Novel pharmacological strategies for driving inflammatory cell apoptosis and enhancing the resolution of inflammation. Trends Pharmacol. Sci. 2008, 29(May (5)):250-257.
13. Hodge S., Hodge G., Holmes M., Reynolds P.N. Increased peripheral blood T-cell apoptosis and decreased Bcl-2 in chronic obstructive pulmonary disease. Immunol. Cell Biol. 2005, 83(April (2)):160-166.
14. Hodge S., Hodge G., Holmes M., Reynolds P.N. Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation. Eur. Respir. J. 2005, 25(March (3)):447-454.
15. Hodge S., Hodge G., Holmes M., Reynolds P.N. Apoptosis in COPD. Curr. Resp. Med. Rev. 2005, 33-41.
16. Ishii T., Matsuse T., Igarashi H., Masuda M., Teramoto S., Ouchi Y. Tobacco smoke reduces viability in human lung fibroblasts: protective effect of glutathione S-transferase P1. Am. J. Physiol. Lung Cell Mol. Physiol. 2001, 280(June (6)):L1189-L1195.
17. Johnson M. Corticosteroids: Potential beta2-agonist and anticholinergic interaction in chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2005, 2:320-325.
18. Kawashima K., Fujii T. Basic and clinical aspects of non-neuronal acetylcholine: overview of non-neuronal cholinergic systems and their biological significance. J. Pharm. Sci. 2008, 106(February (2)):167-173.
19. Kawashima K., Fujii T. Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function. Front. Biosci. 2004, 9(1):2063-2085.
20. Kawashima K., Fujii T. The lymphocytic cholinergic system and its biological function. Life Sci. 2003, 72(March (18-19)):2101-2109.
21. Manicassamy S., Gupta S., Huang Z., Sun Z. Protein kinase C-theta-mediated signals enhance CD4+ T cell survival by up-regulating Bcl-xL. J. Immunol. 2006, 176(11):6709-6716.
22. Pace E., Gagliardo R., Melis M., La Grutta S., Ferraro M., Siena L., Bonsignore G., Gjomarkaj M., Bousquet J., Vignola A.M. Synergistic effects of fluticasone propionate and salmeterol on in vitro T-cell activation and apoptosis in asthma. J. Allergy Clin. Immunol. 2004, 114(5):1216-1223.
23. Pauwels R.A., Buist A.S., Calverley P.M., Jenkins C.R., Hurd S.S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am. J. Respir. Crit. Care Med. 2001, 163(5):1256-1276.
24. Powrie D.J., Wilkinson T.M., Donaldson G.C., Jones P., Scrine K., Viel K., Kesten S., Wedzicha J.A. Effect of Tiotropium on sputum and serum inflammatory markers and exacerbations in COPD. Eur. Respir. J. 2007, 30:472-478.
25. Profita M., Bonanno A., Siena L., Bruno A., Ferraro M., Montalbano A.M., Albano G.D., Riccobono L., Casarosa P., Pieper M.P., Gjomarkaj M. Smoke, choline acetyltransferase, muscarinic receptors, and fibroblast proliferation in chronic obstructive pulmonary disease. J. Pharmacol. Exp. Ther. 2009, 329:753-763.
26. Profita M., Bonanno A., Siena L., Ferraro M., Montalbano A.M., Pompeo F., Riccobono L., Pieper M.P., Gjomarkaj M. Acetylcholine mediates the release of IL-8 in human bronchial epithelial cells by a NFkB/ERK-dependent mechanism. Eur. J. Pharmacol. 2008, 582:145-153.
27. Profita M., Giorgi R.D., Sala A., Bonanno A., Riccobono L., Mirabella F., Gjomarkaj M., Bonsignore G., Bousquet J., Vignola A.M. Muscarinic receptors, leukotriene B4 production and neutrophilic inflammation in COPD patients. Allergy 2005, 60:1361-1369.
28. Stankiewicz W., Dabrowski M.P., Chcialowski A., Plusa T. Cellular and cytokine immunoregulation in patients with chronic obstructive pulmonary disease and bronchial asthma. Mediators Inflamm. 2002, 11:307-312.